ATE230609T1 - Verfahren zur behandlung von entzündungen und zusammensetzungen dafür - Google Patents

Verfahren zur behandlung von entzündungen und zusammensetzungen dafür

Info

Publication number
ATE230609T1
ATE230609T1 AT96909862T AT96909862T ATE230609T1 AT E230609 T1 ATE230609 T1 AT E230609T1 AT 96909862 T AT96909862 T AT 96909862T AT 96909862 T AT96909862 T AT 96909862T AT E230609 T1 ATE230609 T1 AT E230609T1
Authority
AT
Austria
Prior art keywords
serp
compositions
treating inflammation
methods
biologically active
Prior art date
Application number
AT96909862T
Other languages
English (en)
Inventor
D Grant Mcfadden
Alexandra Lucas
Original Assignee
Viron Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viron Therapeutics Inc filed Critical Viron Therapeutics Inc
Application granted granted Critical
Publication of ATE230609T1 publication Critical patent/ATE230609T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT96909862T 1995-03-27 1996-03-26 Verfahren zur behandlung von entzündungen und zusammensetzungen dafür ATE230609T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/411,043 US5939525A (en) 1995-03-27 1995-03-27 Methods of treating inflammation and compositions therefor
PCT/US1996/004054 WO1996030042A2 (en) 1995-03-27 1996-03-26 Methods of treating inflammation and compositions therefor

Publications (1)

Publication Number Publication Date
ATE230609T1 true ATE230609T1 (de) 2003-01-15

Family

ID=23627329

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96909862T ATE230609T1 (de) 1995-03-27 1996-03-26 Verfahren zur behandlung von entzündungen und zusammensetzungen dafür

Country Status (11)

Country Link
US (2) US5939525A (de)
EP (1) EP0817646B1 (de)
JP (1) JPH11503122A (de)
AT (1) ATE230609T1 (de)
AU (1) AU5323396A (de)
CA (1) CA2214988A1 (de)
DE (1) DE69625682T2 (de)
DK (1) DK0817646T3 (de)
ES (1) ES2187646T3 (de)
PT (1) PT817646E (de)
WO (1) WO1996030042A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP508798A0 (en) * 1998-08-05 1998-08-27 Biotech Australia Pty Limited Method of treating psoriasis
AU1123001A (en) * 1999-10-27 2001-05-08 Alexandra Lucas Compositions and methods for preventing and treating transplant rejection
WO2001039790A1 (en) * 1999-12-02 2001-06-07 Viron Therapeutics, Inc. Methods of treating inflammation and compositions therefor
EP1313498A4 (de) * 2000-05-25 2004-04-21 Ben-Tsion Williger Phospholipase d effektoren für therapie und screening
AU2001291579B2 (en) * 2000-09-29 2006-08-31 Viron Therapeutics Inc. Use of serp- 1 in combination with an immunosuppressant for influencing inflammatory and immune reactions
CA2424983A1 (en) * 2000-10-11 2002-04-18 Viron Therapeutics, Inc. Nucleic acid molecules and polypeptides for immune modulation
WO2002046214A2 (en) * 2000-12-04 2002-06-13 Viron Therapeutics Inc. Immunomodulatory protein derived from the yaba monkey tumor virus
US7718368B2 (en) * 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
CN1494425B (zh) * 2001-03-05 2011-12-07 特兰斯泰克制药公司 用作治疗剂的羧酰胺衍生物
AU2002368225A1 (en) * 2001-10-10 2004-05-04 Mount Sinai School Of Medicine Of The City University Of New York Viral interferon antagonists and uses therefor
GB0125594D0 (en) * 2001-10-25 2001-12-19 Univ Sheffield Inhibitors for inactivating allergens
AU2003280252A1 (en) * 2002-11-01 2004-05-25 Alexandra R. Lucas Viral serpin regulation of inflamation
US7285530B2 (en) * 2004-10-21 2007-10-23 Viron Therapeutics, Inc. Use of SERP-1 as an antiplatelet agent
US8251876B2 (en) 2008-04-22 2012-08-28 Hill-Rom Services, Inc. Breathing exercise apparatus
US9180271B2 (en) 2012-03-05 2015-11-10 Hill-Rom Services Pte. Ltd. Respiratory therapy device having standard and oscillatory PEP with nebulizer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206017A (en) * 1986-06-03 1993-04-27 Incyte Pharmaceuticals, Inc. Use of protease nexin-I as an antiinflammatory
EP0512090B2 (de) * 1990-10-16 2006-11-22 Sonoran Desert Chemicals LLC Behandlung von entzündungen
WO1992022320A1 (en) * 1991-06-14 1992-12-23 Genentech, Inc. C1 inhibitor variants and treating inflammatory response with c1 inhibitor
DE4214215A1 (de) * 1992-04-30 1993-11-04 Behringwerke Ag Verwendung von inhibitoren von plasminogenaktivatoren zur behandlung von entzuendungen
WO1995027503A1 (en) * 1994-04-08 1995-10-19 Mcfadden D Grant Antirestenosis protein

Also Published As

Publication number Publication date
CA2214988A1 (en) 1996-10-03
JPH11503122A (ja) 1999-03-23
EP0817646B1 (de) 2003-01-08
US5917014A (en) 1999-06-29
DE69625682D1 (de) 2003-02-13
WO1996030042A2 (en) 1996-10-03
WO1996030042A3 (en) 1996-11-21
US5939525A (en) 1999-08-17
ES2187646T3 (es) 2003-06-16
EP0817646A2 (de) 1998-01-14
AU5323396A (en) 1996-10-16
DK0817646T3 (da) 2003-04-22
PT817646E (pt) 2003-04-30
DE69625682T2 (de) 2003-10-02

Similar Documents

Publication Publication Date Title
ATE230609T1 (de) Verfahren zur behandlung von entzündungen und zusammensetzungen dafür
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
DE69733132D1 (de) Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
ES2166783T3 (es) Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii.
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
DE69535264D1 (de) Verfahren zur behandlung von diabetes mittels kgf
EP1007556A4 (de) Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese
DE69835823D1 (de) Verfahren zur behandlung von patienten die unter multipler sklerose leiden mit konsensus-interferon
DE69703689D1 (de) Therapeutische anwendungen von bpi-protein-produkten zur behandlung von humaner meningococcämia
ATE453402T1 (de) Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis
SE9603725D0 (sv) New teatment
EA199700241A1 (ru) Новые, определенные по составу смеси ферментов для выделения клеток и лечения ран
DE69111974D1 (de) Verwendung von Lithium zur Behandlung oder Prophylaxe von Molluscum contagiusum.
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
GEP20012511B (en) Method for Lowering Level of Lipoproteins (a) in Serum or Plasma of Mammals, Method for Treatment of Peripheral Vascular Diseases or Restenosis
DE69623316D1 (de) Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen
DE69729201T2 (de) Sulfonfluoride zur behandlung von der alzheimerischen krankheit
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
ATE293994T1 (de) Multivalente rekombinante antikörper zur behandlung von hrv infektionen
ATE295731T1 (de) Olanzapine zur behandlung von drogenmissbrauch
NO984198L (no) FremgangsmÕte for behandling av aggresjon
ATE280584T1 (de) Verwendung von beta interferon zur herstellung eines arzneimittels zur behandlung von ewings sarkom und eoe
ATE318612T1 (de) Methoden und zusammensetzungen zur behandlung der hyperlipidämie
MY109685A (en) Method for treating hepatitis b carriers with minimal disease

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0817646

Country of ref document: EP

REN Ceased due to non-payment of the annual fee